Spots Global Cancer Trial Database for An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
Official Title: An Open Label Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (Mechlorethamine - MCH) 0.04% Formulation in Patients With Stage I-IIA Mycosis Fungoides Who Have Completed 12 Months Treatment Without a Complete Response
Study ID: NCT00535470
Conditions
Interventions
Study Description
Brief Summary: To evaluate the efficacy and safety of topical application of MCH 0.04% in a propylene glycol ointment (PG)in patients with stage I or IIA MF previously treated with MCH 0.02% in a PG or AP ointment who did not achieve a complete response.
Detailed Description: This is a multi-center, open-label study of patients with previously treated stage I (IA and IB) or IIA MF who have not received a complete response after completing 12 months of treatment in clinical trial (2005NMMF-201-US)to either 0.02% MCH PG or 0.02% MCH in Aquaphor (AP) ointment formulations.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Stanford University Medical Center, Stanford, California, United States
Northwestern University-Dept. of Dermatology, Chicago, Illinois, United States
Columbia University, Dept of Dermatology, New York, New York, United States
NYU Medical Center Dept. of Dermatology, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Oklahoma University, Tulsa, Oklahoma, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
University of Texas, Southwestern Medical Center, Dallas, Texas, United States
The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States
Utah Clinical Trials, LLC, Salt Lake City, Utah, United States
University of Wisconsin, Madison, Wisconsin, United States
Contact Details
Name: Stuart Lessin, M.D.
Affiliation: Fox Chase Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
